Series B

Following a spin-out and $5M financing, new explorer Blue Jay Gold aims to unlock value at its Steller Project and list on the TSX Venture Exchange.

American Lithium Minerals acquires a high-grade gold claim in BC's Golden Triangle while pivoting to a revolutionary but risky blockchain financing model.

Slingshot Aerospace's TALOS AI will create unpredictable, machine-speed adversaries, revolutionizing how Guardians prepare for orbital conflict.

Four startups won the UAE FoodTech Challenge, sharing $2M to scale their solutions for food production and waste reduction from the UAE to the Global South.

As Moelis & Co. prepares to report its 2025 results, investors are watching to see if the firm capitalized on a record year for dealmaking.

With a new CRO known for driving acquisitions and IPOs, RunSafe Security aims to dominate the critical infrastructure protection market amid rising threats.

Amid rapid industry consolidation, doctor-owned DSO PepperPointe Partnerships adds three VPs to scale its unique model and support continued expansion.

Biotech veteran Kamran Tavangar, who built a multi-billion dollar company at LabCentral, returns to lead its science strategy and shape the future of innovation.

A new partnership aims to move AI from costly experiments to real-world value in biopharma, combining specialized agents with strategic implementation.

With a key FDA decision looming, Orca Bio's massive new funding aims to commercialize a therapy that could make curative transplants safer for more patients.

Pharma giant Lilly and AI biotech BigHat are teaming up to solve a critical flaw in AI drug discovery, aiming to unlock a new generation of therapies.

TwelveStone Health Partners and AI firm Tennr are teaming up to automate patient referrals, aiming to slash wait times and improve access to vital care.

A landmark $1.2M order for its advanced LineaDNA validates the firm's biotech arm, but can scientific success balance its new, volatile crypto strategy?

A new drug could redefine life for polycythemia vera patients, replacing frequent, burdensome blood draws with a simple weekly self-injection.

The junior explorer has raised crucial capital to advance its drilling programs in Quebec's prolific gold belt, signaling strong investor confidence.

The popular brunch chain is betting on a digital marketing guru to transform its customer experience and accelerate growth in a tech-driven market.

AI e-commerce firm Teikametrics hires Walmart Business co-founder Daryk Pengelly, signaling a major push for strategic growth and market dominance.

Facing soaring demand, AI robotics firm TechForce is seeking a global manufacturing partner, signaling a major shift from pilot programs to mass production.

The AI investment frenzy is shifting from GPUs to the physical world of power, cooling, and real estate, creating a new class of high-value companies.

Pharma giant GSK partners with biotech CAMP4, leveraging novel RNA-boosting tech to develop new therapies for neurodegenerative and kidney diseases.